Financials
- Market Capitalization 28.95 M
- Employee 70
- Founded 2005
- CEO N/A
- Website www.igcinc.us
- Headquarter Maryland, United States
- FIGI BBG000NSSLY8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.17
Fiyat/satışlar oranı
17.16
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4431 | QNCX Quince Therapeutics, Inc. - Common Stock | 29.55 USD | +2.04% | -7.31% | -5.71% | +1746.88% | 30.05 M USD | ||
| 4442 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.67 USD | 0.00% | +4.69% | -6.94% | -38.53% | 29.14 M USD | ||
| 4448 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.69 USD | 0.00% | -14.65% | -51.58% | -82.23% | 28.61 M USD | ||
| 4464 | CVM Cel-Sci Corporation Common Stock | 1.50 USD | -1.32% | -10.18% | +0.67% | -70.87% | 26.38 M USD |